Biotechnology - Financial

Filter

Current filters:

Financial

Popular Filters

1 to 25 of 430 results

Australia: Foresight to translate research into treatments, devices and diagnostics

29-01-2015

Amid the growing realization that Australian research needs support to make it a reality, the Queensland…

AustraliaBiotechnologyFinancialResearch

Amgen’s 4th-qtr 2014 earnings and sales beat expectations

Amgen’s 4th-qtr 2014 earnings and sales beat expectations

28-01-2015

US biotech major Amgen reported financial results after markets closed yesterday, revealing that fourth-quarter…

AmgenBiotechnologyFinancialUSA

Innovation and confidence at JP Morgan conference, says Edison analyst

26-01-2015

The atmosphere at this year's annual JPMorgan Conference in San Francisco was understandably buoyant,…

BiotechnologyFinancialMergers & AcquisitionsResearch

Low dollar tipped to stimulate biotech investment in Australia

15-01-2015

Analyst commentary suggests the devaluation of the Australian dollar during 2014, has left biotech in…

ActinogenAustraliaBenitec BiopharmaBiotechnologyFinancialMergers & AcquisitionsSirtex Medical

New biotech Solvanix launched in Australia with start-up investment from the MRCF

15-01-2015

Solvanix Pty Ltd, an early stage biotechnology company with a novel technology for improving stability…

AustraliaBiotechnologyFinancialResearchSolvanixStAbilize

Merck & Co inks discovery and development deal with Moderna

Merck & Co inks discovery and development deal with Moderna

13-01-2015

Privately-held Moderna Therapeutics has entered into a license and collaboration agreement with US pharma…

Anti-viralsBiotechnologyFinancialMerck & CoModerna TherapeuticsResearchUSAVaccines

Biotech industry shatters key fundraising records in 2014

08-01-2015

The biotech industry shattered records for venture investment, IPOs (initial public offerings) and M&A…

BiotechnologyFinancialGlobalLicensing

NewLink Genetic and Merck Ebola collaboration gets $30 million government award

23-12-2014

US biotech firm NewLink Genetics saw its shares gain 4.1% to $40.11 in morning trading on Monday, following…

Anti-viralsBiotechnologyFinancialMerck & CoNewLink GeneticsResearchTropical diseasesUSA

Stem cell sector offers investors high returns to rejuvenate their investment portfolios

Stem cell sector offers investors high returns to rejuvenate their investment portfolios

22-12-2014

Dr Husein K Salem, founder and chief executive of Precious Cells Group (PCG), one of the UK’s leading…

BiotechnologyFinancialMarkets & MarketingPrecious Cells GroupResearch

Sorrento and Conkwest join forces on cancer immunotherapies development

Sorrento and Conkwest join forces on cancer immunotherapies development

19-12-2014

US cancer drug developer Sorrento Therapeutic and privately-held Conkwest have entered into a definitive…

BiotechnologyConkwestFinancialNeukoplastOncologyResearchSorrento Therapeutics

Novartis venture fund leads $34 million financing for Annexon Bioscience

Novartis venture fund leads $34 million financing for Annexon Bioscience

17-12-2014

USA-based Annexon Bioscience says it has closed a $34 million Series A-1 to support the development of…

Annexon BioscienceANX005BiotechnologyFinancialNeurologicalNovartis

Valneva and BliNK Therapeutics launch new biotech company

Valneva and BliNK Therapeutics launch new biotech company

12-12-2014

France-based biotech firm Valneva and privately-held UK company BliNK Therapeutics have created a private…

BiotechnologyBliNK BiomedicalBliNK TherapeuticsFinancialFranceMergers & AcquisitionsUKValneva

AusBiotech reflects on a year of advocacy and achievement

AusBiotech reflects on a year of advocacy and achievement

11-12-2014

For the Australian biotechnology industry and for trade group AusBiotech, the past year has been another…

AustraliaBiotechnologyFinancialPoliticsResearch

Credit Suisse sees PTC Therapeutics as a top stock pick

05-12-2014

Credit Suisse has released a biotech research report from analysts Jason Kantor and Jeremiah Shepard…

BiotechnologyFinancialNeurologicalPTC TherapeuticsRare diseasesRegulationTranslarna

AusBiotech argues for boosting commercial returns from research

05-12-2014

Trade group AusBiotech has made a submission to the Australian federal government’s consultation regarding…

AustraliaBiotechnologyFinancialPoliticsResearch

AstraZeneca to invest $200 million in expanding US biologics manufacturing center

22-11-2014

Anglo-Swedish pharma major AstraZeneca on Friday unveiled plants to expand its biologics manufacturing…

AstraZenecaBiotechnologyFinancialMedImmuneProductionUSA

Royalty Pharma pays $3.3 billion for CFF royalty rights to Kalydeco

19-11-2014

Royalty Pharma says it has acquired royalties on Vertex Pharmaceuticals' cystic fibrosis treatments,…

BiotechnologyFinancialKalydecoRare diseasesRoyalty PharmaVertex Pharmaceuticals

Onxeo receives $25M milestone payment from Spectrum on Beleodaq

14-11-2014

Onxeo, created by a merger between French company BioAlliance Pharma, and Danish biopharmaceutical company…

BeleodaqBiotechnologyFinancialHematologyLicensingOncologyOnxeoSpectrum PharmaceuticalsUSA

Increased scrutiny by EU5 health authorities will encourage off-label use of Avastin for wet-AMD

06-11-2014

Cost-constrained health authorities in the EU5 (France, Germany, Italy, Spain, and the UK) are increasingly…

AvastinBiosimilarsBiotechnologyEuropeFinancialLucentisMarkets & MarketingNovartisOphthalmicsRoche

Genmab reports nine month interim results, including $31 million revenue increase on 2013

Genmab reports nine month interim results, including $31 million revenue increase on 2013

06-11-2014

Danish biotech company Genmab has reported its nine-month interim results, including an increase in revenue…

BiotechnologydaratumumabDenmarkDuoBodyFinancialGenmabOfatumumab Injection

Regeneron third-qtr net profit plunges despite strong sales growth

Regeneron third-qtr net profit plunges despite strong sales growth

04-11-2014

US biotech firm Regeneron posted revenue of $725.8 million for the third quarter of 2014, a rise of 22%…

alirocumabBayerBiotechnologydupilumabEyleaFinancialOphthalmicsRegeneronResearchSanofisarilumab

Pharming strengthens balance sheet with $20 million milestone from Salix

Pharming strengthens balance sheet with $20 million milestone from Salix

04-11-2014

Dutch biotech company Pharming Group says it has received a $20 million milestone payment from the USA’s…

BiotechnologyFinancialPharming GroupRare diseasesRuconestSalix Pharmaceuticals

Celladon links with Lonza for commercial manufacturing of Mydicar

03-11-2014

Swiss chemical supplier Lonza and US biotech firm Celladon Corp have entered into an agreement providing…

BiotechnologyCardio-vascularCelladonFinancialLonzaProduction

Affinivax launches, aiming to develop novel conjugate vaccine

30-10-2014

Affinivax, a US biotechnology company dedicated to developing novel vaccines, today announced its launch…

AffinivaxBiotechnologyFinancialResearchVaccines

1 to 25 of 430 results

Back to top